136 related articles for article (PubMed ID: 29390357)
1. Association between rs11200014, rs2981579, and rs1219648 polymorphism and breast cancer susceptibility: A meta-analysis.
Zhang Y; Lu H; Ji H; Lu L; Liu P; Hong R; Li Y
Medicine (Baltimore); 2017 Dec; 96(50):e9246. PubMed ID: 29390357
[TBL] [Abstract][Full Text] [Related]
2. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
[TBL] [Abstract][Full Text] [Related]
3. Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis.
Yang YB; Zhao ZX; Huang W; Liu H; Tan YL; Wang WM
J Cancer Res Ther; 2016; 12(2):543-9. PubMed ID: 27461607
[TBL] [Abstract][Full Text] [Related]
4. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.
Zhou L; Yao F; Luan H; Wang Y; Dong X; Zhou W; Wang Q
Breast Cancer Res Treat; 2012 Dec; 136(3):885-97. PubMed ID: 23124475
[TBL] [Abstract][Full Text] [Related]
5. Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(42):68002-68011. PubMed ID: 27634905
[TBL] [Abstract][Full Text] [Related]
6. Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.
Cui F; Wu D; Wang W; He X; Wang M
Breast Cancer Res Treat; 2016 Jan; 155(2):313-35. PubMed ID: 26728143
[TBL] [Abstract][Full Text] [Related]
7. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
Jia C; Cai Y; Ma Y; Fu D
Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
[TBL] [Abstract][Full Text] [Related]
9. Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects.
Dai ZJ; Kang HF; Wang XJ; Shao YP; Lin S; Zhao Y; Ren HT; Min WL; Wang M; Liu XX
Cancer Cell Int; 2014; 14(1):91. PubMed ID: 25253995
[TBL] [Abstract][Full Text] [Related]
10. Association between Interleukin-8-251A/T polymorphism and gastric cancer susceptibility: a meta-analysis based on 5286 cases and 8000 controls.
Zhang Y; Zeng X; Lu H; Li Y; Ji H
Int J Clin Exp Med; 2015; 8(12):22393-402. PubMed ID: 26885219
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
[TBL] [Abstract][Full Text] [Related]
12. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
[TBL] [Abstract][Full Text] [Related]
13. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
14. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC
Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749
[TBL] [Abstract][Full Text] [Related]
15. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
Wang H; Yang Z; Zhang H
Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
[TBL] [Abstract][Full Text] [Related]
16. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
19. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.
Chen Q; Shi R; Liu W; Jiang D
PLoS One; 2013; 8(8):e72487. PubMed ID: 23977306
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
